Literature DB >> 10471458

Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene.

A Pietrangelo1, G Montosi, A Totaro, C Garuti, D Conte, S Cassanelli, M Fraquelli, C Sardini, F Vasta, P Gasparini.   

Abstract

BACKGROUND AND METHODS: Hereditary hemochromatosis in adults is usually characterized by mutations in the HFE gene on the short arm of chromosome 6. Most patients have a substitution of tyrosine for cysteine at position 282 (C282Y). We studied a large family from Italy that includes persons who have a hereditary iron-overload condition indistinguishable from hemochromatosis but without apparent pathogenic mutations in the HFE gene. We performed biochemical, histologic, and genetic studies of 53 living members of the family, including microsatellite analysis of chromosome 6 and direct sequencing of the HFE gene.
RESULTS: Of the 53 family members, 15 had abnormal serum ferritin levels, values for transferrin saturation that were higher than 50 percent, or both. Thirteen of the 15 had elevated body iron levels, diagnosed on the basis of the clinical evaluation and liver biopsy, and underwent iron-removal therapy. The other two, both children, did not undergo liver biopsy or iron-removal therapy. None of the 15 members had the C282Y mutation of the HFE gene; 5 of the 15 (as well as 5 healthy relatives) had another mutation of this gene, a substitution of aspartate for histidine at position 63, but none were homozygous for it. No other mutations were found after sequencing of the entire HFE gene for all family members. Microsatellite analysis showed no linkage of the hemochromatosis phenotype with the short arm of chromosome 6, the site of the HFE gene.
CONCLUSIONS: Hereditary hemochromatosis can occur in adults who do not have pathogenic mutations in the hemochromatosis gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471458     DOI: 10.1056/NEJM199909023411003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  45 in total

1.  Population screening for haemochromatosis.

Authors:  P C Adams
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding.

Authors:  R E Fleming; W S Sly
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 4.  Iron overload due to mutations in ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Giovanni Musci; Jerry Kaplan
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

5.  Disease progression and liver cancer in the ferroportin disease.

Authors:  Elena Corradini; Francesca Ferrara; Teresa Pollicino; Alberto Vegetti; Gian Luca Abbati; Luisa Losi; Giovanni Raimondo; Antonello Pietrangelo
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

6.  Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

Authors:  De-Liang Zhang; Manik C Ghosh; Hayden Ollivierre; Yan Li; Tracey A Rouault
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

Review 7.  Ferroportin-mediated iron transport: expression and regulation.

Authors:  Diane M Ward; Jerry Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-03-13

8.  Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.

Authors:  XinJing Wang; Catherine Leiendecker-Foster; Ronald T Acton; James C Barton; Christine E McLaren; Gordon D McLaren; Victor R Gordeuk; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2009-01-26       Impact factor: 3.039

9.  High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy.

Authors:  Giovanni Squadrito; Marcello Previti; Marco Lenzi; Enrico Pagano Le Rose; Gaia Caccamo; Tea Restuccia; Enrico Di Cesare; Teresa Pollicino; Giovanni Raimondo
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 10.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.